Valeant Pharmaceuticals International, Inc. 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Dec 3, 2014
Insider Transaction Report
Form 4
STEVENSON KATHARINE BERGHUIS
Director
Transactions
- Purchase
Common Stock, no par value
2014-12-03$145.73/sh+1,500$218,595→ 23,098 total
Footnotes (1)
- [F1]This number represents the weighted average purchase price for all purchases of common stock. Actual purchases were in the range of $145.68 and $145.83. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each price.